PrognomiQ: Funding, Investors & Team (Oct 2026)
PrognomiQ is a biotechnology firm that develops test products for the early detection and treatment of cancer and other complex diseases through the power of multi-omics data.
PrognomiQ has raised $46.0M across 1 funding round on record, the most recent an undisclosed round of $46.0M announced in Mar 2022.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
PrognomiQ Company Profile and Key Stats
Latest funding round on record: Mar 2022.
PrognomiQ Funding Rounds
PrognomiQ Founders and Leadership Team
Contact details for the PrognomiQ team: 1 of 1 has an email address on file.
Start 14-day free trial →PrognomiQ Funding Compared to Other Biotechnology Startups
PrognomiQ's latest round of $46.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like PrognomiQ in Biotechnology and San Mateo
Companies Similar to PrognomiQ
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
PrognomiQ Funding FAQs
What does PrognomiQ do?
PrognomiQ is a biotechnology firm that develops test products for the early detection and treatment of cancer and other complex diseases through the power of multi-omics data.
How much funding has PrognomiQ raised?
PrognomiQ has raised $46.0M across 1 round on record. The most recent is an undisclosed round of $46.0M announced in Mar 2022.
When did PrognomiQ last raise funding?
PrognomiQ's most recent funding round on record is an undisclosed round of $46.0M, announced in Mar 2022.
Who is the CEO of PrognomiQ?
Philip Ma is listed as CEO at PrognomiQ.
Where is PrognomiQ headquartered?
PrognomiQ is based in San Mateo, California, United States.
How many employees does PrognomiQ have?
PrognomiQ is in the 11-50 employee band.
How does PrognomiQ's funding compare to other Biotechnology startups?
PrognomiQ's latest round of $46.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's PrognomiQ Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for PrognomiQ is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.